medigraphic.com
SPANISH

Revista Mexicana de Urología

Organo Oficial de la Sociedad Mexicana de Urología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 6

<< Back Next >>

Rev Mex Urol 2019; 79 (6)

Bibliometric analysis: Milestones in sexual medicine, erectil dysfunction therapies over time

Camilo ÁJ, Reveiz N, García-Perdomo HA
Full text How to cite this article

Language: Spanish
References: 25
Page: 1-10
PDF size: 929.50 Kb.


Key words:

History of medicine, Urology, Sexual dysfunction, Testosterone, Phosphodiesterase 5 inhibitors, Bibliometrics.

ABSTRACT

Background: The development of sexual medicine has a broad historic background, from mystic and religious understandings of conception and virility to the pathophysiologic understanding of fertilization and erection. New therapeutic treatments have emerged from a historic knowledge of sexual medicine. Unlike other disciplines, sexual medicine has maintained different management options throughout its history.
Objective: The aim of the present article was to analyze and evaluate publication trends in sexual medicine to evaluate erectile dysfunction behavior and its indicated therapies over a twenty-year period, providing a temporal description of changes in paradigms in this branch of medicine, as well as of its development and associated research.
Methodology: A bibliometric analysis by five-year periods, utilizing PubMed, was carried out.
Conclusion: There was an increased trend in publications related to testosterone, phosphodiesterase type 5 inhibitors, and antioxidants, whereas the number of articles on vacuum systems remained steady. The present analysis reveals that there is still much to be explored in the field of sexual medicine


REFERENCES

  1. Porst H, Burnett A, Brock G, Ghanem H, Giuliano F, Glina S, et al. SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med. 2013 Jan;10(1):130–71. doi: https://doi.org/10.1111/jsm.12023

  2. Jara Rascon J, Lledó García E. La Medicina Sexual en la Historia. Avances y controversias (Parte I). Revista Internacional de Andrología. 2013 Jul 1;11(3):107–14. doi: https://doi. org/10.1016/j.androl.2013.02.004

  3. Jara Rascon J, Lledó García E. La Medicina Sexual en la Historia. Avances y controversias (Parte II). Revista Internacional de Andrología. 2013 Oct 1;11(4):149–57. doi: https://dx.doi. org/10.1016/j.androl.2013.02.003

  4. Lewis RW. The History of Modern Sexual Medicine. In: IsHak W, editor. The Textbook of Clinical Sexual Medicine. Springer International Publishing; 2017. p. 17–23. [accessed 3 Dec 2019] Available from: https://doi. org/10.1007/978-3-319-52539-6

  5. Nieschlag E, Nieschlag S. Testosterone deficiency: a historical perspective. Asian J Androl. 2014 Apr;16(2):161–8. doi: https://doi. org/10.4103/1008-682X.122358

  6. Jonas U. The history of erectile dysfunction management. International Journal of Impotence Research. 2001 Aug;13(3):S3–7. doi: https://doi.org/10.1038/sj.ijir.3900717

  7. Yafi FA, Jenkins L, Albersen M, Corona G, Isidori AM, Goldfarb S, et al. Erectile dysfunction. Nat Rev Dis Primers. 2016 04;2:16003. doi: https:// doi.org/10.1038/nrdp.2016.3

  8. Pastuszak AW. Current Diagnosis and Management of Erectile Dysfunction. Curr Sex Health Rep. 2014 Sep;6(3):164–76. doi: https:// doi.org/10.1007/s11930-014-0023-9

  9. Corona G, Isidori AM, Buvat J, Aversa A, Rastrelli G, Hackett G, et al. Testosterone Supplementation and Sexual Function: A Meta- Analysis Study. The Journal of Sexual Medicine. 2014 Jun 1;11(6):1577–92. doi: https://doi. org/10.1111/jsm.12536

  10. Ng E, Woo HH, Turner S, Leong E, Jackson M, Spry N. The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression. The Journal of Urology. 2012 Jun 1;187(6):2162–7. doi: https://doi.org/10.1016/j.juro.2012.01.080

  11. Gannon JR, Walsh TJ. Testosterone and Sexual Function. Urologic Clinics of North America. 2016 May 1;43(2):217–22. doi: https://doi. org/10.1016/j.ucl.2016.01.008

  12. Zurawin JL, Stewart CA, Anaissie JE, Yafi FA, Hellstrom WJG. Avanafil for the treatment of erectile dysfunction. Expert Review of Clinical Pharmacology. 2016 Sep 1;9(9):1163–70. doi: https://doi.org/10.1080/17512433.2016.12126 55

  13. Castiglione F, Albersen M, Hedlund P, Gratzke C, Salonia A, Giuliano F. Current Pharmacological Management of Premature Ejaculation: A Systematic Review and Metaanalysis. European Urology. 2016 May 1;69(5):904–16. doi: https://doi.org/10.1016/j. eururo.2015.12.028

  14. Sun Y, Luo D, Yang L, Tang C, Yang T, Hu X, et al. Efficacy of Phosphodiesterase-5 Inhibitor in Men With Premature Ejaculation: A New Systematic Review and Meta-analysis. Urology. 2015 Nov 1;86(5):947–55. doi: https://doi. org/10.1016/j.urology.2015.06.051

  15. Rew KT, Heidelbaugh JJ. Erectile Dysfunction. American family physician. 2016;94(10):820–7.

  16. Levine LA, Becher E, Bella A, Brant W, Kohler T, Martinez-Salamanca JI, et al. Penile Prosthesis Surgery: Current Recommendations From the International Consultation on Sexual Medicine. The Journal of Sexual Medicine. 2016 Apr 1;13(4):489–518. doi: http://dx.doi. org/10.1016/j.jsxm.2016.01.017

  17. Trost L, Wanzek P, Bailey G. A practical overview of considerations for penile prosthesis placement. Nat Rev Urol. 2016 Jan;13(1):33–46. doi: https://doi.org/10.1038/nrurol.2015.270

  18. Padma-Nathan H, Hellstrom WJG, Kaiser FE, Labasky RF, Lue TF, Nolten WE, et al. Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil. New England Journal of Medicine. 1997 Jan 2;336(1):1–7. doi: 10.1056/NEJM199701023360101

  19. Costa P, Potempa A-J. Intraurethral alprostadil for erectile dysfunction: a review of the literature. Drugs. 2012 Dec 3;72(17):2243– 54. doi: https://doi.org/10.2165/11641380- 000000000-00000

  20. Padma-Nathan H, Yeager JL. An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients. Urology. 2006 Aug 1;68(2):386–91. doi: https://doi.org/10.1016/j.urology.2006.02.027

  21. Fojecki GL, Tiessen S, Osther PJS. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie’s disease, erectile dysfunction and chronic pelvic pain. World J Urol. 2017 Jan 1;35(1):1–9. doi: https://doi.org/10.1007/ s00345-016-1834-2

  22. Lu Z, Lin G, Reed-Maldonado A, Wang C, Lee Y-C, Lue TF. Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis. European Urology. 2017 Feb 1;71(2):223–33. doi: https:// doi.org/10.1016/j.eururo.2016.05.050

  23. Brison D, Seftel A, Sadeghi-Nejad H. The resurgence of the vacuum erection device (VED) for treatment of erectile dysfunction. J Sex Med. 2013 Apr;10(4):1124–35. doi: https:// doi.org/10.1111/jsm.12046

  24. Levine LA, Dimitriou RJ. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am. 2001 May;28(2):335–41, ix–x. doi: https://doi. org/10.1016/s0094-0143(05)70142-7

  25. Krzastek SC, Bopp J, Smith RP, Kovac JR. Recent advances in the understanding and management of erectile dysfunction. F1000Res. 2019 Jan 25;8:102. doi: https://doi.org/10.12688/ f1000research.16576.1




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Urol. 2019;79